Crossref Citations
This article has been cited by the following publications. This list is generated based on data provided by Crossref.
Toal, M.
and
Campbell, H.
1998.
Prescribing of atypical antipsychotics.
British Journal of Psychiatry,
Vol. 173,
Issue. 1,
p.
85.
Appadoo, R.
Ashton, C.
and
Carlton, T.
1998.
[No Title].
British Journal of Psychiatry,
Vol. 173,
Issue. 1,
p.
85.
Möller, H.-J.
and
Soyka, M.
1998.
Flupentixol — Typisches oder atypisches Wirkspektrum?.
p.
1.
Reid, S.
and
Turner, J.
1998.
Amisulpride in schizophrenia.
British Journal of Psychiatry,
Vol. 172,
Issue. 5,
p.
450.
Thomas, C.
and
Lewis, S.
1998.
Authors' reply.
British Journal of Psychiatry,
Vol. 173,
Issue. 1,
p.
85.
Ram, Jai Ranjan
and
Vanstraellen, M.
1999.
Use of antipsychotics by child and adolescent psychiatrists.
Psychiatric Bulletin,
Vol. 23,
Issue. 3,
p.
182.
Palmer, Barton W.
Heaton, Shelley C.
and
Jeste, Dilip V.
1999.
Older Patients With Schizophrenia: Challenges in the Coming Decades.
Psychiatric Services,
Vol. 50,
Issue. 9,
p.
1178.
Jeste, Dilip V
Palmer, Barton W
and
Harris, M.Jackuelyn
1999.
Neuroleptic discontinuation in clinical and research settings: scientific issues and ethical dilemmas.
Biological Psychiatry,
Vol. 46,
Issue. 8,
p.
1050.
Gilbody, Simon M
and
Petticrew, Mark
1999.
Rational decision-making in mental health: the role of systematic reviews.
The Journal of Mental Health Policy and Economics,
Vol. 2,
Issue. 3,
p.
99.
Osser, David N
and
Zarate, Carlos A
1999.
Consultant for the Pharmacotherapy of Schizophrenia.
Psychiatric Annals,
Vol. 29,
Issue. 5,
p.
252.
Pandarakalam, James Paul
2000.
Atypical neuroleptics.
Hospital Medicine,
Vol. 61,
Issue. 1,
p.
10.
Murphy, BE
Bagnall, A
Chue, P
Fenton, M
Leitner, M
Wood, J
and
Murphy, Brendan Eugene
2000.
Cochrane Database of Systematic Reviews.
Emsley, Robin A.
2000.
Role of Newer Atypical Antipsychotics in the Management of Treatment- Resistant Schizophrenia.
CNS Drugs,
Vol. 13,
Issue. 6,
p.
409.
Williams, H.
Clarke, R.
Bouras, N.
Martin, J.
and
Holt, G.
2000.
Use of the atypical antipsychotics Olanzapine and Risperidone in adults with intellectual disability.
Journal of Intellectual Disability Research,
Vol. 44,
Issue. 2,
p.
164.
Voruganti, L
Cortese, L
Oyewumi, L
Cernovsky, Z
Zirul, S
and
Awad, A
2000.
Comparative evaluation of conventional and novel antipsychotic drugs with reference to their subjective tolerability, side-effect profile and impact on quality of life.
Schizophrenia Research,
Vol. 43,
Issue. 2-3,
p.
135.
McDonough, M.
Hillery, J.
and
Kennedy, N.
2000.
Olanzapine for chronic, stereotypic self‐injurious behaviour: a pilot study in seven adults with intellectual disability.
Journal of Intellectual Disability Research,
Vol. 44,
Issue. 6,
p.
677.
McDonough, M.
Hillery, J.
and
Kennedy, N.
2000.
Olanzapine for chronic, stereotypic self-injurious behaviour: a pilot study in seven adults with intellectual disability.
Journal of Intellectual Disability Research,
Vol. 44,
Issue. 6,
p.
677.
Solomons, Kevin
and
Geiger, Odie
2000.
Olanzapine Use in the Elderly: A Retrospective Analysis.
The Canadian Journal of Psychiatry,
Vol. 45,
Issue. 2,
p.
151.
Oosthuizen, Piet
Emsley, Robin A.
Turner, Jadri
and
Keyter, Natasha
2001.
Determining the optimal dose of haloperidol in first-episode psychosis.
Journal of Psychopharmacology,
Vol. 15,
Issue. 4,
p.
251.
Rapoport, Mark J.
van Reekum, Robert
Freedman, Morris
Streiner, David
Simard, Martine
Clarke, Diana
Cohen, Tammy
and
Conn, David
2001.
Relationship of psychosis to aggression, apathy and function in dementia.
International Journal of Geriatric Psychiatry,
Vol. 16,
Issue. 2,
p.
123.
eLetters
No eLetters have been published for this article.